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Introduction
Community-acquired pneumonia (CAP) is the leading cause 
of death from infectious disease in the United States. [1] 
Guidelines for the management of hospitalized patients with 
CAP have been structured around the results of clinical research 
activities. Although there is a wealth of data in this area, there 
are still important knowledge gaps for the management of 
hospitalized patients with CAP that will need to be resolved with 
further clinical research.  Training new individuals is imperative 
to produce a new generation of clinical investigators with the 
expertise necessary to fill these gaps in knowledge. Within the 
University of Louisville Division of Infectious Diseases, we have 
implemented novel clinical research training programs with this 
goal in mind.
In these courses, several challenges were discovered when 
teaching biostatistics. First, although a comprehensive 
understanding of all statistical methodologies used in a 
particular field is ideal, in practice this may be unnecessary. By 
attempting to teach with a goal of comprehensive understanding, 
practical ideas are lost in a sea of formulas. Furthermore, clinical 
investigators are often intimidated by their unfamiliarity with 
statistics. In an attempt to resolve some of these challenges, we 
consider that it is important to limit statistical teaching to the 
most pertinent tests and topics in clinical research. Although 
this knowledge does not replace the importance of enlisting 
the expertise of a biostatistician for all stages of a research 
project, it does facilitate a broad understanding of the basic 
concepts of biostatistics and assists in critical analysis of study 
results. This knowledge leads to higher quality studies and a 
better understanding of how results of other studies can be 
incorporated into clinical practice. 
The primary objective of this study is to define the most common 
statistical methodologies in recent clinical studies of CAP to 
inform teaching approaches in the field. Secondary objectives 
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were to: 1) define the most common study designs, 2) define 
statistical tests to be included in a curriculum to educate clinical 
investigators interested in clinical research of CAP, 3) generate a 
glossary defining the most common statistical tests.
Methods
This was a literature review including recent publications in the 
field of CAP. Articles were eligible for inclusion in this study if 
they: 1) were clinical research with an emphasis on incidence, 
epidemiology, or patient outcomes, 2) were searchable via 
PubMed or Google Scholar, 3) were published within the 
timeframe of January 1st 2012 to August 1st 2017, 4) contained 
Medical Subject Headings (MeSH) keywords of “pneumonia” 
and one of the following: “epidemiologic studies”, “health 
services research”, or “comparative effectiveness research” or 
search keywords of “community-acquired pneumonia”  and 
one of the following: “cohort study”, “observational study”, 
“prospective study”, “retrospective study”, “clinical trial”, 
“controlled trial”, or “clinical study”. A Delphi panel of CAP 
clinical investigators decided by vote on which 30 articles to 
include in this review based on their clinical relevance and 
applicability to clinical practice.
Only statistics mentioned in the body of the article were included 
in our evaluation; information in supplementary appendices 
were not evaluated. 
Statistical methodologies were divided into five categories: 1) 
descriptive statistics, 2) inferential statistics and procedures, 3) 
graphics and figures, 4) study design, and 5) statistical software.
Descriptive statistics were performed to summarize the tests and 
procedures performed, represented by frequency and percent. 
The most frequent statistical methodologies were reported. R 
software version 3.3.2 was used for all analysis.
A test was considered for curriculum if it was present in more 
than 30% of the articles reviewed. Based on this criterion, we 
identified statistical tests to be included in a curriculum to 
educate individuals interested in clinical research of CAP. Tests 
were grouped into sessions based on their application in clinical 
research.
Using this curriculum, we developed a glossary for the most 
common statistical tests for clinical investigators in the field of 
CAP. Definitions were written so that they are meaningful to 
non-statisticians and did not include mathematical formulae.
Results
Thirty studies were evaluated based on decisions by the Delphi 
panel [2-31]. Study characteristics are shown in Table 1. Every 
study that was evaluated included a descriptive analysis of 
patient characteristics. Every study included frequencies for 
various descriptive analyses, notated by n, and percent. Medians 
were the most frequently reported measures of central tendency 
(n=22 [73%]), and interquartile ranges (IQRs; n=19 [63%]) 
were the most frequently reported measure of variability.
P-values were reported in 27 (90%) studies. In 19 (63%) 
studies, cutoff values for statistical significance were explicitly 
stated. Confidence intervals were reported in 21 (70%) studies. 
Bivariate comparisons were performed most commonly with 
Wilcoxon rank sum tests (n=16 [53%]) and Chi-squared tests 
(n=20 [67%]). Multivariable analyses were most commonly 
logistic regression (n=17 [60%]) and Cox Proportional Hazards 
regression (n=10 [33%]).
Table 1. Study characteristics
The most common figure was study flow diagram (n=17 [57%]). 
The most common graphic was a bar chart (n=8 [27%]).
The majority of studies were cohort studies (n=19, [63%]). The 
majority of cohort studies were prospective (n=13, [68%]).
The most frequent software used was SPSS (n=9, [30%]). Five 
studies (17%) mentioned multiple software used, and eight 
studies (27%) did not specify which software was used for 
analysis.
Six statistical tests occurred in more than 30% of the articles 
reviewed. These tests were: Chi-squared tests, Fisher’s exact 
tests, t-tests, Wilcoxon Rank Sum tests, logistic regression, and 
Cox Proportional Hazards regression. Curriculum session are 
depicted in Table 2.
A glossary defining the most common statistical tests is depicted 
in Table 3.
Variable n (%) Study Design  Retrospective 7 (23) Prospective 23 (77) Cohort       Prospective       Retrospective 19 (63) 13 (68) 6 (32) Case-Control 1 (3) Randomized Controlled Trial 10 (33) Descriptive Statistics   n 30 (100) % 30 (100) Mean 16 (53) Standard Deviation 13 (43) Median 22 (73) Interquartile Range 19 (63) Minimum 1 (3) Maximum 1 (3) Analyses or procedures  Type I error rate or significance level (alpha) 14 (47) Power (concerning sample size) 4 (13) p values 27 (90) Confidence Intervals 21 (70) T-test (or Z-test) 13 (43) Shapiro-Wilk’s test 1 (3) Wilcoxon Rank Sum test 16 (53) Chi-squared test 20 (67) Fisher’s Exact test 17 (57) McNemar’s test 1 (3) One Way Analysis of Variance 4 (13) Linear Regression 1 (3) Linear Mixed Model 1 (3) Logistic Regression 18 (60) Hosmer-Lemeshow test 5 (17) Poisson Regression 1 (3) Log-Rank test 3 (10) Cox Regression 10 (33) Positive/Negative Predictive Value 2 (7) Area under the curve 3 (10) Sensitivity analysis 8 (27) Multiple imputation adjustment 2 (7) Attributable Fractions 1 (3) Non-Inferiority testing 4 (13) Graphics or Figures  Study Flowchart or Diagram 17 (57) Pie Charts 2 (7) Bar Charts 8 (27) Line Charts 2 (7) Kaplan Meier Curves 6 (20) ROC Curve 6 (20) 
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Table 2. Statistical Test Curriculum for Clinical Investigators
Table 3. Glossary of terms
Discussion
Our study defined the most frequent statistics and tests used in 
clinical research of CAP. The most common descriptive statistics 
for categorical data were frequencies and percentages. The most 
common descriptive statistics for continuous data were medians 
and IQRs. The most common statistical tests can be split 
into two types: comparing study sample characteristics, and 
comparing study sample outcomes. Concerning study sample 
characteristics, the most common tests for categorical data were 
chi-squared tests, or Fisher’s exact tests. The most common test 
for comparing continuous data between two study groups was 
the Wilcoxon rank sum test.
Tests comparing outcomes were led primarily by study design. 
In cohort studies, logistic regression was the most common test 
for outcome analysis. In randomized controlled trials, analyses 
were much more varied, with the most common test for outcome 
analysis being Cox Proportional Hazards Regression analysis.
Sessions of curriculum were chosen based on the application 
of tests in clinical research. Our data suggests a minimum 
requirement of four sessions for a basic core statistical 
curriculum. The t-test and Wilcoxon rank sum test are both 
used to compare continuous data between two study groups, 
so these were combined in the curriculum. Likewise, the chi-
squared test and Fisher’s exact test both compare categorical 
data between study groups, so these were also combined. While 
the curriculum will contain more detail on each analytical 
approach, the glossary provied in Table 3 gives a fact sheet for 
clinical investigators on the kinds of tests they should expect to 
see within clinical research in the field of CAP. 
An important limitation is that we concentrated only on clinical 
research, which is a single topic within the large field of CAP. In 
order to develop a curriculum for generalized clinical research, 
a more comprehensive review of clinical studies should be 
performed. Furthermore, we did not evaluate whether or not 
each statistical methodology or study design was appropriate for 
each hypothesis tested. It is possible that other methodologies 
may have been better suited to answer each of the questions 
posed by the investigators.
Finally, as articles were chosen by vote from a Delphi panel, it is 
possible that there may be bias in our results, or that our results 
may not be replicated by other researchers.
In conclusion, we identified the most common clinical research 
tests performed in studies of hospitalized patients with CAP. 
Junior investigators should become very familiar with these 
tests early in their research careers. 
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